Retinal Disease
Showing NaN - NaN of 6
Retinitis Pigmentosa, Usher Syndrome Type 2, Deaf Blind Trial in Worldwide (Ultevursen, Sham-procedure)
Recruiting
- Retinitis Pigmentosa
- +7 more
- Ultevursen
- Sham-procedure
-
San Diego, California
- +14 more
Jul 29, 2022
Retinitis Pigmentosa, Usher Syndrome Type 2, Deaf Blind Trial in Dallas, Madison, London (QR-421a, Sham-procedure)
Active, not recruiting
- Retinitis Pigmentosa
- +7 more
- QR-421a
- Sham-procedure
-
Dallas, Texas
- +2 more
Apr 21, 2022
Retinitis Pigmentosa, Usher Syndrome Type 2, Deaf Blind Trial in Canada, France, United States (QR-421a, Sham-procedure (dose
Completed
- Retinitis Pigmentosa
- +7 more
- QR-421a
- Sham-procedure (dose cohort 1&2 only)
-
Boston, Massachusetts
- +6 more
Apr 19, 2022
Dry Age-related Macular Degeneration, Geographic Atrophy, Macular Degeneration Trial in United States (GEM103)
Terminated
- Dry Age-related Macular Degeneration
- +4 more
-
Phoenix, Arizona
- +28 more
Mar 22, 2022
Neovascular Age-related Macular Degeneration, Retinal Disease, Retinal Degeneration Trial in United States (GEM103, sham + SoC)
Completed
- Neovascular Age-related Macular Degeneration
- +3 more
- GEM103
- sham + SoC
-
Phoenix, Arizona
- +22 more
Mar 22, 2022
Natural Progression of Dry Age-related Macular Degeneration
Recruiting
- Dry Age-related Macular Degeneration
- +5 more
-
Phoenix, Arizona
- +65 more
Feb 22, 2021